Clinical Trial

The Use of Indocyanine Green Fluorescence (ICG) During Laparoscopic Heller- Dor

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 23, 2025 (before its estimated October 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim this prospective observational study is to evaluate the role of Indocyanine Green Fluorescence (ICG) in patients with achalasia underwent to Heller-Dor laparoscopic. The main gol are: * If with use of ICG iatrogenic mucosal leaks can be identified and, if necessary, improve the myotomy. * Assess the need for postoperative radiographic control using esophagogastric radiography with gastrografin. * Compare clinical characteristics, perioperative outcomes, and 12-month postoperative follow-up between the two populations.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-11.
Trial Details
NCT Number NCT07181070
Lead Sponsor Federico II University
Conditions Achalasia, Esophageal, Achalasia, Indocyanine Green (ICG), Indocyanine Green
Enrollment 70 participants
Start Date 2022-11-01
Primary Completion 2025-10-31 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-23